Search
Menu
Home
Sources
About
Contacts
Bivatuzumab mertansine
Bivatuzumab
mertansine
is a
combination
of
bivatuzumab
, a
humanized monoclonal antibody
, and mertansine, a
cytotoxic agent
. It is
designed
for the
treatment
of
squamous cell carcinoma
.